Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd Share Issue/Capital Change 2021

Jan 27, 2021

59255_rns_2021-01-27_fa8fdb7e-dd10-44bd-b931-8d20f01de9f5.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [100 x 31] intentionally omitted <==

27[th] January, 2021

To, To,
BSE Limited, The Manager,
25, P. J. Towers, Listing Department,
Dalal Street, National Stock Exchange of India Ltd.,
Mumbai – 400 001 Exchange Plaza, Bandra Kurla Complex,
**Ref:**Company Scrip Code: 532834 Bandra (East), Mumbai‐ 400051
**Ref:Symbol:**CAMLINFINE

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)

Dear Sir/Madam,

This is to inform that the Company has allotted 12,750 equity shares of face value of Re.1/‐ each in accordance with the terms of ESOP 2018, on 20[th] January, 2021.

Consequent to the said allotment the paid up share capital of the Company has gone up to 12,74,84,721 equity shares of face value of Re.1/‐ each aggregating to Rs. 12,74,84,721/‐. The said shares have been listed on the exchanges on 27[th] January, 2021.

Thanking You,

For Camlin Fine Sciences Limited

==> picture [55 x 52] intentionally omitted <==

==> picture [83 x 35] intentionally omitted <==

Mr. Mandar Godbole GM Legal & Company Secretary (Membership No – 30240)

==> picture [426 x 57] intentionally omitted <==